FMGKX | VIGIX | FMGKX / VIGIX | |
Total Expense Ratio | 0.35 | 0.04 | 875% |
Annual Report Gross Expense Ratio | 0.35 | 0.04 | 875% |
Fund Existence | 17 years | 27 years | - |
Gain YTD | -9.717 | -12.153 | 80% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 33.6B | 261B | 13% |
Annual Yield % from dividends | 0.29 | 0.52 | 55% |
Returns for 1 year | -3.12 | 8.89 | -35% |
Returns for 3 years | 8.04 | 37.19 | 22% |
Returns for 5 years | 39.17 | 105.70 | 37% |
Returns for 10 years | 39.03 | 230.15 | 17% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PSCI | 113.21 | 1.93 | +1.73% |
Invesco S&P SmallCap Industrials ETF | |||
NCV | 12.65 | 0.17 | +1.36% |
Virtus Convertible & Income Fund | |||
FBT | 157.64 | 2.01 | +1.29% |
First Trust NYSE Arca Biotech ETF | |||
VMBS | 45.66 | 0.13 | +0.29% |
Vanguard Mortgage-Backed Secs ETF | |||
UCIB | 25.80 | 0.03 | +0.12% |
UBS ETRACS BgCstMtCdy(CMCI)TtlRetETNSerB |